Sam Jockel, Alston & Bird: Healthy claims, bioengineered labeling
Sam Jockel, senior associate, Alston & Bird: One thing I’m watching for in 2022 is the role of changes to labeling requirements in product and packaging formulation decisions. This may include, for example, reformulation of products to comply with the expected revision to FDA’s 'healthy' nutrient content claim, shifts in the ingredient supply chain in response to mandatory bioengineered food disclosure, or closer scrutiny placed on the use of food packaging materials in response to updated requirements for environmental marketing claims. COVID-19 will likely continue to impact these decisions with disrupted ingredient and packaging supply chains into 2022.
